Coronary and aortic vasoconstriction by cathinone, the active constituent of khat

Autonomic and Autacoid Pharmacology

Volumn 23, Issue 5-6, 2003, Pages 319-326

  Al Motarreb, A L ^a   Broadley, K J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aorta; Cathinone; Cocaine; Perfused hearts; Prazosin; Vasoconstriction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CATHA EDULIS EXTRACT; CATHINONE; COCAINE; NORADRENALIN; NOREPHEDRINE; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CHRONOTROPISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; DRUG POTENCY; GUINEA PIG; INOTROPISM; INTRINSIC SYMPATHOMIMETIC ACTIVITY; ISOLATED HEART; MALE; NONHUMAN; TACHYPHYLAXIS; VASCULAR RING;

ALKALOIDS; ANIMALS; AORTA, THORACIC; CATHA; COCAINE; CORONARY CIRCULATION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; GUINEA PIGS; HEART RATE; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; PERFUSION; PHENYLPROPANOLAMINE; PLANT LEAVES; PRAZOSIN; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 3442888921     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2004.00303.x     Document Type: Article

References (23)

1. AL-MOTARREB, A., BAKER, K. & BROADLEY, K.J. (2002a). Khat: pharmacological and medical aspects and its social use in Yemen. Phytother. Res., 16, 403-413.
2. AL-MOTARREB, A., AL-KEBSI, M., AL-ADHI, B. & BROADLEY, K.J. (2002b). Khat chewing and acute myocardial infarction. Heart, 87, 279-280.
3. BRENNEISEN, R. & GEISSHUSLER, S. (1985). Psychotropic drugs. III. Analytical and chemical aspects of Catha edulis Forsk. Pharm. Acta Helv., 60, 290-301.
4. BRENNEISEN, R., GEISSHUSLER, S. & SCHORNO, X. (1986). Metabolism of cathinone to (-)-norephedrine and (-)-norpseudoephedrine. J. Pharm. Pharmacol., 38, 298-300.
5. BRENNEISEN R., FISCH, H.U., KOELBING, U., GEISSHUSLER, S. & KALIX, P. (1990). Amphetamine-like effects in humans of the khat alkaloid cathinone. Br. J. Clin. Pharmacol., 30, 825-828.
6. BROADLEY, K.J. (1996). Autonomic Pharmacology. Taylor & Francis, London.
7. COWAN, F.F., CANNON, C., KOPPANYI, T. & MAENGWYN-DAVIES, G.D. (1961). Reversal of phenylalkylamine tachyphylaxis by norepinephrine. Science, 134, 1069-1070.
8. DAY, M.D. (1967). The lack of crossed tachyphylaxis between tyramine and some other indirectly acting sympathomimetic amines. Br. J. Pharmacol. Chemother., 30, 631-643.
9. FOLTIN, R. & SCHUSTER, C. (1982). Behavioral tolerance and cross-tolerance to dl-cathinone and d-amphetamine. J. Pharmacol. Exp. Ther., 222, 126-131.
10. GUGELMANN, R., von ALLMEN, M., BRENNEISEN, R. & PORZIG, H. (1985). Quantitative differences in the pharmacological effects of (+) and (-) cathinone. Experiencia, 41, 1568-1571.
11. HALKET, J.M., KARASU, Z. & MURRAY-LYON, I.M. (1995). Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk.). J. Ethnopharmacol., 49, 111-113.
12. 3H-norepinephrine. Life Sci., 32, 801-807.
13. KALIX, P. (1984). The pharmacology of khat. Gen. Pharmacol., 15, 179-187.
14. KALIX, P. (1992). Cathinone, a natural amphetamine. Pharmacol. Toxicol., 70, 77-86.
15. KALIX, P. & BRAENDEN, O. (1985). Pharmacological aspects of the chewing of khat leaves. Pharmacol. Rev., 37, 149-164.
16. KENAKIN, T.P. (1980). Errors in the measurement of agonist potency-ratios produced by uptake processes. A general model applied to β-adrenoceptor agonists. Br. J. Pharmacol., 71, 407-417.
17. KNOLL, J. (1979). Studies on the central effects of (-)cathinone. In: Problems of Drug Dependence. NIDA Research Monograph 27. pp. 322-333. US Government Printing Office, Washington, DC.
18. KOHLI, J. & GOLDBERG, L. (1982). Cardiovascular effect of (-)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine. J. Pharm. Pharmacol., 34, 338-340.
19. MOYA-HUFF, F.A. & MAHER, T.J. (1987). Adrenergic receptor subtype activation by (+)-, (-)- and (±)-norephedrine in the pithed rat. J. Pharm. Pharmacol., 39, 108-112.
20. MOYA-HUFF, F.A., KIRITSY, P.J. & MAHER, T.J. (1987). Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat. J. Pharm. Sci., 76, 114-116.
21. STANASZEK, W.F., KELLERMAN, D., BROGDEN, R.N. & ROMANKIEWICZ, J.A. (1983). Prazosin update. A review of its pharmacological properties and therapeutic uses in hypertension and congestive heart failure. Drugs, 25, 339-384.
22. WIDLER, P., MATHYS, K., BRENNEISEN, R., KALIX, P. & FISCH, H.-U. (1994). Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin. Pharmacol. Ther., 55, 556-562.
23. ZELGER, J. & CARLINI, E. (1980). Anorexigenic effects of two amines obtained from Cata edulis in rats. Pharmacol. Biochem. Behav., 12. 701-705.